ABC.L Regulatory News (ABC)

16 Sep 2009 17:25



 ("Abcam" or "the Company")

Director's Dealings 

Cambridge, UK: Abcam plc (AIM: ABC), the rapidly growing bioscience company that markets antibodies via its own online catalogue, announces that the following transactions were undertaken by Directors of the Company on 16 September 2009:

*4,000 of these shares were sold by his wife Jane Dominey.

For further information please contact:

Notes for editors:

About Abcam plc

Abcam is a producer and distributor of research-grade antibodies headquartered in Cambridge, United Kingdom, with offices in Cambridge, Massachusetts, USA and Tokyo, Japan. Abcam was admitted to AIM in November 2005 and trades under the ticker symbol ABC. The Company produces and distributes its own and third-party produced antibodies to academic and commercial users throughout the world. Product ordering is available through the Company's website www.abcam.com, where customers are also able to access up-to-date and detailed technical product data sheets. All the antibodies are sold under the Abcam brand name and the Company's vision is to build the world's largest online resource of high-quality and commercially viable antibodies. Abcam now has an online catalogue of over 52,000 products, most of which are antibodies, from over 250 suppliers and employs 237 staff in its three operating companies.